Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
|Active Ingredient:||Pembrolizumab 25mg/mL|
|Dosage Form:||Concentrate for infusion|
|New Zealand Sponsor:||Merck Sharp & Dohme (New Zealand) Limited|
|Manufacturer:||MSD International GmbH, t/a MSD Ireland (Carlow), Carlow, Ireland|
Dated this 10th day of September 2021.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).